Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes
Authors:
- Miquel FerrerMFMiquel Ferrer
- Josep Maria SierraJSJosep Maria Sierra
- Dolors SoyDSDolors Soy
- Laura GuerreroLGLaura Guerrero
- Jordi VilaJordi Vila
- Gianluigi Li BassiGBGianluigi Li Bassi
- Núria CortadellasNCNúria Cortadellas
- Pilar Martínez-OlondrisPMPilar Martínez-Olondris
- Montserrat Mvd RigolMRMontserrat Mvd Rigol
- Mariano EsperattiMEMariano Esperatti
- Néstor LuqueNLNéstor Luque
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (8) , 2385-2389
Abstract
Objective: To evaluate the effects of systemic treatment with linezolid compared with vancomycin on biofilm formation in mechanically ventilated pigs with severe methicillin-resistant Staphylococcus aureus–induced pneumonia. Design: Prospective randomized animal study. Setting: Departments of Pneumology, Microbiology, and Pharmacy of the Hospital Clínic, Barcelona, and Scientific and Technological Services of the University of Barcelona. Subjects: We prospectively analyzed 70 endotracheal tube samples. Endotracheal tubes were obtained from pigs either untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). Interventions: The endotracheal tubes were obtained from a previous randomized study in tracheally intubated pigs with methicillin-resistant Staphylococcus aureus severe pneumonia, and mechanically ventilated for 69 ± 16 hrs. Measurements and Main Results: Distal and medial hemisections of the endotracheal tube were assessed to quantify methicillin-resistant Staphylococcus aureus burden, antibiotic biofilm concentration by high-performance liquid chromatography or bioassay, and biofilm thickness through scanning electron microscopy. We found a trend toward a significant variation in biofilm methicillin-resistant Staphylococcus aureus burden (log colony-forming unit/mL) among groups (p = .057), and the lowest bacterial burden was found in endotracheal tubes treated with linezolid (1.98 ± 1.68) in comparison with untreated endotracheal tubes (3.72 ± 2.20, p = .045) or those treated with vancomycin (2.97 ± 2.43, p = .286). Biofilm linezolid concentration was 19-fold above the linezolid minimum inhibitory concentration, whereas biofilm vancomycin concentration (1.60 ± 0.91 µg/mL) was consistently below or close to the vancomycin minimum inhibitory concentration. Biofilm was thicker in the vancomycin group (p = .077). Conclusions: Systemic treatment with linezolid limits endotracheal tube biofilm development and methicillin-resistant Staphylococcus aureus burden. The potential clinical usefulness of linezolid in decreasing the risk of biofilm-related respiratory infections during prolonged tracheal intubation requires further investigation.Keywords
This publication has 39 references indexed in Scilit:
- Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Bacterial biofilms: from the Natural environment to infectious diseasesNature Reviews Microbiology, 2004
- Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US DatabaseChest, 2002
- Biofilms as Complex Differentiated CommunitiesAnnual Review of Microbiology, 2002
- Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Antibiotic resistance of bacteria in biofilmsThe Lancet, 2001
- Mechanisms of biofilm resistance to antimicrobial agentsTrends in Microbiology, 2001
- Bacterial Biofilms: A Common Cause of Persistent InfectionsScience, 1999
- Electron microscopic evaluation of bacterial adherence to polyvinyl chloride endotracheal tubes used in neonatesCritical Care Medicine, 1989
- Nosocomial pulmonary infectionCritical Care Medicine, 1986